Approval · Notice of Compliance 4657 · 1996
SEREVENT: Notice of Compliance 4657
Issued October 2, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4657
- Date
- October 2, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Bronchodilator (b2-adrenergic stimulant)
Products in this notice
Medicinal ingredients
- SALMETEROL XINAFOATE 25 MCG per ACT
- SALMETEROL XINAFOATE 50 MCG per PCK